로딩 중…
지수 로딩 중…
Rapport Therapeutics, Inc. Common Stock
RAPP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$37.34+1.27%
2026-06-18
Price Chart
Rapport Therapeutics, Inc. Common Stock+238.53%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.79B |
| Revenue | $20M |
| Net Income | $-107M |
| Total Assets | $498M |
| Net Assets | $472M |
| Value | |
| P/B | 3.79x |
| P/S | 89.29x |
| FCF Yield | -4.51% |
| Profitability | |
| ROE | -22.75% |
| ROA | -21.56% |
| Op. Margin | -611.03% |
| Financial Health | |
| Debt Ratio | 5.53% |
| Total Debt | $11M |
| FCF | $-81M |
| Cash | $78M |
| Current Ratio | 27.08x |
| Performance | |
| 1Y Return | 238.53% |
| 1M Return | 8.64% |
| From 52W High | -11.66% |
| 1Y MDD | -28.82% |
| Trading | |
| Volume | 339,144 shares |
| Trading Value | $13M |
| Per Share | |
| EPS | $-2.37 |
| BPS | $10.32 |